FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshimi Misu

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Disorders

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Naoko Matsushita; Yoshimi Misu; Yoshio Goshima
In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
Jun-ichi Izawa; Kaori Yamanashi; Taro Asakura; Yoshimi Misu; Yoshio Goshima
Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats.
M Shimamura; M Shimizu; T Yagami; T Funabashi; F Kimura; Y Kuroiwa; Yoshimi Misu; Yoshio Goshima
L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshimi Misu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Naoko Matsushita; Yoshimi Misu; Yoshio Goshima
In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
European journal of pharmacology 2009;605(1-3):109-13.
2006: Jun-ichi Izawa; Kaori Yamanashi; Taro Asakura; Yoshimi Misu; Yoshio Goshima
Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats.
European journal of pharmacology 2006;549(1-3):84-90.
2006: M Shimamura; M Shimizu; T Yagami; T Funabashi; F Kimura; Y Kuroiwa; Yoshimi Misu; Yoshio Goshima
L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
Neuropharmacology 2006;50(8):909-16.
2003: Yoshimi Misu; Kunio Kitahama; Yoshio Goshima
L-3,4-Dihydroxyphenylalanine as a neurotransmitter candidate in the central nervous system.
Pharmacology & therapeutics 2003;97(2):117-37.
2002: Yoshimi Misu; Nobuya Furukawa; Nobutaka Arai; Takeaki Miyamae; Yoshio Goshima; Kiyohide Fujita
DOPA causes glutamate release and delayed neuron death by brain ischemia in rats.
Neurotoxicology and teratology 2002;24(5):629-38.
2002: Kaori Yamanashi; Takeaki Miyamae; Yukio Sasaki; Masanobu Maeda; Hideyasu Hirano; Yoshimi Misu; Yoshio Goshima
Involvement of nitric oxide production via kynurenic acid-sensitive glutamate receptors in DOPA-induced depressor responses in the nucleus tractus solitarii of anesthetized rats.
Neuroscience research 2002;43(3):231-8.
2002: Yoshimi Misu; Yoshio Goshima; Takeaki Miyamae
Is DOPA a neurotransmitter?
Trends in pharmacological sciences 2002;23(6):262-8.
2001: Kaori Yamanashi; Takeaki Miyamae; Yoshimi Misu; Yoshio Goshima
Tonic function of nicotinic receptors in stress-induced release of L-DOPA from the nucleus accumbens in freely moving rats.
European journal of pharmacology 2001;424(3):199-202.
2001: Takao Kubo; T Yokoi; Yukihiko Hagiwara; Ryuji Fukumori; Yoshio Goshima; Yoshimi Misu
Characteristics of protective effects of NMDA antagonist and calcium channel antagonist on ischemic calcium accumulation in rat hippocampal CA1 region.
Brain research bulletin 2001;54(4):413-9.
2001: Nobutaka Arai; Nobuya Furukawa; Takeaki Miyamae; Yoshio Goshima; Y Sasaki; E Ohshima; F Suzuki; Kiyohide Fujita; Yoshimi Misu
DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats.
Neuroscience letters 2001;299(3):213-6.
2001: Nobuya Furukawa; Nobutaka Arai; Yoshio Goshima; Takeaki Miyamae; E Ohshima; F Suzuki; Kiyohide Fujita; Yoshimi Misu
Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata.
Journal of neurochemistry 2001;76(3):815-24.
2001: Y Sugaya; Y Sasaki; Yoshio Goshima; K Kitahama; T Kusakabe; Takeaki Miyamae; T Kato; Yoshimi Misu
Autoradiographic studies using L-[(14)C]DOPA and L-DOPA reveal regional Na(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS.
Neuroscience 2001;104(1):1-14.
2000: H Ishiia; Y Sasaki; Yoshio Goshima; Y Kanai; H Endou; D Ayusawa; H Ono; Takeaki Miyamae; Yoshimi Misu
Involvement of rBAT in Na(+)-dependent and -independent transport of the neurotransmitter candidate L-DOPA in Xenopus laevis oocytes injected with rabbit small intestinal epithelium poly A(+) RNA.
Biochimica et biophysica acta 2000;1466(1-2):61-70.
2000: Nobuya Furukawa; Yoshio Goshima; Takeaki Miyamae; Y Sugiyama; M Shimizu; E Ohshima; F Suzuki; Nobutaka Arai; Kiyohide Fujita; Yoshimi Misu
L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds.
Japanese journal of pharmacology 2000;82(1):40-7.
1999: Takashi Nakayama; Yoshio Goshima; Yoshimi Misu; T Kato
Role of cdk5 and tau phosphorylation in heterotrimeric G protein-mediated retinal growth cone collapse.
Journal of neurobiology 1999;41(3):326-39.
1999: Yoshio Goshima; Nobuya Furukawa; Nobutaka Arai; Takeaki Miyamae; Y Sasaki; M Hashimoto; I Yamamoto; Kiyohide Fujita; A Akaike; Yoshimi Misu
[A DOPA antagonist, DOPA cyclohexyl ester inhibits transient brain ischemia-induced release of glutamate and delayed neuronal cell death in striatal and hippocampal region of in vivo rats].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1999;114 Suppl 1():180P-185P.
1999: Itsuo Gorai; Osamu Chaki; Y Taguchi; M Nakayama; H Osada; N Suzuki; N Katagiri; Yoshimi Misu; H Minaguchi
Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
Calcified tissue international 1999;65(1):16-22.
1999: Yoshio Goshima; H Hori; Yukio Sasaki; T Yang; M Kagoshima-Maezono; Chanxia Li; Toshifumi Takenaka; Fumio Nakamura; Takuya Takahashi; S M Strittmatter; Yoshimi Misu; Tadashi Kawakami
Growth cone neuropilin-1 mediates collapsin-1/Sema III facilitation of antero- and retrograde axoplasmic transport.
Journal of neurobiology 1999;39(4):579-89.
1999: Yoshio Goshima; K Honjo; Takeaki Miyamae; Yoshimi Misu
The evidence for tonic GABAergic regulation of basal L-DOPA release via activation of inhibitory GABA(A) receptors in the nucleus tractus solitarii of anesthetized rats.
Neuroscience letters 1999;261(3):155-8.
1999: K Honjo; Yoshio Goshima; Takeaki Miyamae; Yoshimi Misu
GABA may function tonically via GABA(A) receptors to inhibit hypotension and bradycardia by L-DOPA microinjected into depressor sites of the nucleus tractus solitarii in anesthetized rats.
Neuroscience letters 1999;261(1-2):93-6.
1999: Takeaki Miyamae; Yoshio Goshima; J L Yue; Yoshimi Misu
L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.
Neuroscience 1999;92(1):137-49.
1999: M Nishihama; Takeaki Miyamae; Yoshio Goshima; F Okumura; Yoshimi Misu
An L-dopaergic relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and its cardiovascular function in anesthetized rats.
Neuroscience 1999;92(1):123-35.
1999: Takeaki Miyamae; Yoshio Goshima; M Shimizu; T Shibata; K Kawashima; E Ohshima; F Suzuki; Yoshimi Misu
Some interactions of L-DOPA and its related compounds with glutamate receptors.
Life sciences 1999;64(12):1045-54.
1998: Yoshimi Misu; Nobuya Furukawa; Nobutaka Arai; Takeaki Miyamae; Yoshio Goshima
[Is endogenously released DOPA itself an upstream factor for increase in glutamate release and delayed neuronal cell death induced by transient ischemia in rats?].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1998;112 Suppl 1():93P-97P.
1998: N Fukushima; M Kohno; T Kato; S Kawamoto; K Okuda; Yoshimi Misu; Hiroshi Ueda
Melittin, a metabostatic peptide inhibiting Gs activity.
Peptides 1998;19(5):811-9.
1998: Yoshimi Misu; Yoshio Goshima; J L Yue; Takeaki Miyamae
Is L-DOPA a neurotransmitter of the primary baroreceptor afferents terminating in the nucleus tractus solitarii of rats?
Advances in pharmacology (San Diego, Calif.) 1998;42():855-8.
1997: Yoshimi Misu; Yoshio Goshima; Takeaki Miyamae; Nobuya Furukawa; Y Sugiyama; Y Okumura; M Shimizu; E Ohshima; F Suzuki
L-DOPA cyclohexyl ester is a novel stable and potent competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester.
Japanese journal of pharmacology 1997;75(3):307-9.
1997: T Maeda; N Cheng; Toshiaki Kume; Shuji Kaneko; H Kouchiyama; Akinori Akaike; M Ueda; Masamichi Satoh; Y Goshima; Yoshimi Misu
L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons.
Brain research 1997;771(1):159-62.
1997: Yoshimi Misu; Yoshio Goshima; Takeaki Miyamae; Nobuya Furukawa; Y Okumura; Y Sugiyama; M Shimizu
[Studies on novel, stable and potent competitive antagonists against L-DOPA].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1997;110 Suppl 1():159P-164P.
1997: Yoshio Goshima; Tadashi Kawakami; H Hori; Yoshinobu Sugiyama; S Takasawa; Y Hashimoto; M Kagoshima-Maezono; Toshifumi Takenaka; Yoshimi Misu; S M Strittmatter
A novel action of collapsin: collapsin-1 increases antero- and retrograde axoplasmic transport independently of growth cone collapse.
Journal of neurobiology 1997;33(3):316-28.
1997: Nobuya Furukawa; Yoshio Goshima; Takeaki Miyamae; M Nishihama; F Okumura; Kiyohide Fujita; Yoshimi Misu
An L-DOPA-like depressor action of L-threo-dihydroxyphenyl-serine in the rat caudal ventrolateral medulla.
Life sciences 1997;61(12):1177-83.
1996: Yoshio Goshima; Takeaki Miyamae; S Nakamura; K Miki; K Kosaka; Yoshimi Misu
Ventral tegmental injection of nicotine induces locomotor activity and L-DOPA release from nucleus accumbens.
European journal of pharmacology 1996;309(3):229-33.
1996: Yoshimi Misu; Yoshio Goshima; H Ueda; H Okamura
Neurobiology of L-DOPAergic systems.
Progress in neurobiology 1996;49(5):415-54.
1996: Takeaki Miyamae; J L Yue; Yoshio Goshima; Yoshimi Misu
Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
European journal of pharmacology 1996;300(1-2):105-8.
1995: J L Yue; Takeaki Miyamae; H Ueda; Yoshimi Misu
Altered basal release and pressor effect of L-DOPA in the rostral ventrolateral medulla of spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S43-5.
1995: Yoshimi Misu; J L Yue; Y Okumura; Takeaki Miyamae; H Ueda
Altered basal release and depressor effect of L-DOPA in the nucleus tractus solitarii of spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S34-6.
1995: Yoshimi Misu; J L Yue; Takeaki Miyamae; Yoshio Goshima
Altered L-DOPA systems for blood pressure regulation in the lower brainstem of spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18(4):267-77.
1995: H Ueda; Takeaki Miyamae; N Fukushima; S Watanabe; Yoshimi Misu
Evidence for a metabostatic opioid kappa-receptor inhibiting pertussis toxin-sensitive metabotropic glutamate receptor-currents in Xenopus oocytes.
FEBS letters 1995;375(3):201-5.
1995: H Ueda; K Sato; F Okumura; Yoshimi Misu
L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats.
Brain research 1995;698(1-2):213-6.
1995: C Hayashi; H Ueda; N Fukushima; T Katayama; Yoshimi Misu
Protein kinase C inhibitor potentiates the agonist-induced GTPase activity in COS cell membranes expressing delta-opioid receptor.
Brain research. Molecular brain research 1995;33(2):347-50.
1995: H Ueda; Takeaki Miyamae; C Hayashi; S Watanabe; N Fukushima; Y Sasaki; T Iwamura; Yoshimi Misu
Protein kinase C involvement in homologous desensitization of delta-opioid receptor coupled to Gi1-phospholipase C activation in Xenopus oocytes.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(11):7485-99.
1995: Takeaki Miyamae; J L Yue; Y Okumura; Yoshio Goshima; Yoshimi Misu
Loss of tonic neuronal activity to release L-DOPA in the caudal ventrolateral medulla of spontaneously hypertensive rats.
Neuroscience letters 1995;198(1):37-40.
1995: H Ueda; Takeaki Miyamae; N Fukushima; H Takeshima; K Fukuda; Y Sasaki; Yoshimi Misu
Opioid mu- and kappa-receptor mediate phospholipase C activation through Gi1 in Xenopus oocytes.
Brain research. Molecular brain research 1995;32(1):166-70.
1995: J L Yue; Y Okumura; Takeaki Miyamae; H Ueda; Yoshimi Misu
Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats.
Neuroscience 1995;67(1):95-106.
1995: Yoshimi Misu; H Ueda; Yoshio Goshima
Neurotransmitter-like actions of L-DOPA.
Advances in pharmacology (San Diego, Calif.) 1995;32():427-59.
1995: H Ueda; K Sato; F Okumura; A Inoue; Y Nakata; N Ozaki; J L Yue; Yoshimi Misu
Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1995;49(4):169-77.
1994: H Ueda; Takeaki Miyamae; N Fukushima; Yoshimi Misu
Protein kinase inhibitor potentiates opioid delta-receptor currents in Xenopus oocytes.
Neuroreport 1994;5(15):1985-8.
1994: J L Yue; H Okamura; Yoshio Goshima; S Nakamura; M Geffard; Yoshimi Misu
Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats.
Neuroscience 1994;62(1):145-61.
1994: K Sato; H Ueda; F Okumura; Yoshimi Misu
6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats.
Brain research 1994;655(1-2):233-6.
1994: N Fukushima; H Ueda; C Hayashi; T Katayama; Takeaki Miyamae; Yoshimi Misu
Species and age-dependent differences of functional coupling between opioid delta-receptor and G-proteins and possible involvement of protein kinase C in striatal membranes.
Neuroscience letters 1994;176(1):55-8.
1994: A Inoue; H Ueda; Y Nakata; Yoshimi Misu
Supersensitivity of quinpirole-evoked GTPase activation without changes in gene expression of D2 and Gi protein in the striatum of hemi-dopaminergic lesioned rats.
Neuroscience letters 1994;175(1-2):107-10.
1994: K Sato; H Ueda; F Okumura; Yoshimi Misu
Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
Neuroscience letters 1994;173(1-2):59-62.
1994: S Nakamura; J L Yue; Yoshio Goshima; Takeaki Miyamae; H Ueda; Yoshimi Misu
Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
Neuroscience letters 1994;170(1):22-6.
1994: J L Yue; S Nakamura; H Ueda; Yoshimi Misu
Endogenously released L-dopa itself tonically functions to potentiate postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
Neuroscience letters 1994;170(1):107-10.
1994: J L Yue; H Ueda; Yoshimi Misu
Evidence for a dopamine receptor subtype sensitive to combination of D1 with D2 antagonist in measurement of G-protein activity using rat striatal membranes.
Life sciences 1994;54(23):PL413-8.
1993: J L Yue; Yoshio Goshima; Takeaki Miyamae; Yoshimi Misu
Evidence for L-dopa relevant to modulation of sympathetic activity in the rostral ventrolateral medulla of rats.
Brain research 1993;629(2):310-4.
1993: Takeaki Miyamae; N Fukushima; Yoshimi Misu; H Ueda
Delta opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes.
FEBS letters 1993;333(3):311-4.
1993: J L Yue; Yoshio Goshima; Yoshimi Misu
Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats.
Neuroscience letters 1993;159(1-2):103-6.
1993: Yoshio Goshima; K Ohno; S Nakamura; Takeaki Miyamae; Yoshimi Misu; A Akaike
L-dopa induces Ca(2+)-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices.
Brain research 1993;617(1):167-70.
1993: Yoshimi Misu; S Nakamura; Yoshio Goshima; J L Yue; Takeaki Miyamae; T Kubo
Review on the relationship between nicotinic acetylcholine receptors and dopaminergic neurotransmission in the central nervous system--dopa is an endogenous neuroactive substance.
Yakubutsu, seishin, kōdō = Japanese journal of psychopharmacology 1993;13(3):199-210.
1993: K Sato; F Okumura; Yoshio Goshima; Takeaki Miyamae; Yoshimi Misu
L-dopa potentiates presynaptic inhibitory alpha 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices.
Japanese journal of pharmacology 1993;62(1):119-22.
1993: S Nakamura; Yoshio Goshima; J L Yue; Takeaki Miyamae; Yoshimi Misu
Endogenously released DOPA is probably relevant to nicotine-induced increases in locomotor activities of rats.
Japanese journal of pharmacology 1993;62(1):107-10.
1993: Yoshimi Misu; Yoshio Goshima
Is L-dopa an endogenous neurotransmitter?
Trends in pharmacological sciences 1993;14(4):119-23.
1992: J L Yue; Yoshio Goshima; S Nakamura; Yoshimi Misu
L-dopa-like regulatory actions of L-threo-3,4-dihydroxyphenylserine on the release of endogenous noradrenaline via presynaptic receptors in rat hypothalamic slices.
The Journal of pharmacy and pharmacology 1992;44(12):990-5.
1992: N Matsushita; M Kuwahara; Yoshio Goshima; Yoshimi Misu
Effects of nanomolar to submillimolar carteolol on noradrenaline release in the absence and presence of uptake1 and uptake2 blockers in guinea pig pulmonary arteries.
Journal of pharmacobio-dynamics 1992;15(12):687-92.
1992: S Nakamura; Yoshio Goshima; J L Yue; Takeaki Miyamae; Yoshimi Misu
Transmitter-like 3,4-dihydroxyphenylalanine is tonically released by nicotine in striata of conscious rats.
European journal of pharmacology 1992;222(1):75-80.
1992: T Kubo; J L Yue; Yoshio Goshima; S Nakamura; Yoshimi Misu
Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat.
Neuroscience letters 1992;140(2):153-6.
1992: K Sato; M Kuwahara; Yoshio Goshima; Yoshimi Misu
Coexistence of presynaptic beta 1- and beta 2-adrenoceptors in splenic strips from young rats and betaxolol-induced beta 1-stereoselective antagonism.
Archives internationales de pharmacodynamie et de thérapie 1992;317():47-55.
1992: S Nakamura; Yoshio Goshima; J L Yue; Yoshimi Misu
Transmitter-like basal and K(+)-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis.
Journal of neurochemistry 1992;58(1):270-5.
1991: Yoshio Goshima; S Nakamura; K Ohno; Yoshimi Misu
Picomolar concentrations of L-dopa stereoselectively potentiate activities of presynaptic beta-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices.
Neuroscience letters 1991;129(2):214-6.
1991: Yoshio Goshima; S Nakamura; Yoshimi Misu
L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
The Journal of pharmacology and experimental therapeutics 1991;258(2):466-71.
1991: T Kubo; Minoru Kihara; Yoshimi Misu
Ipsilateral but not contralateral blockade of excitatory amino acid receptors in the caudal ventrolateral medulla inhibits aortic baroreceptor reflex in rats.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(1):46-51.
1991: Yoshio Goshima; Yoshimi Misu; N Arai; K Misugi
Nanomolar L-dopa facilitates release of dopamine via presynaptic beta-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson's disease.
Japanese journal of pharmacology 1991;55(1):93-100.
1990: T Kubo; Yoshio Goshima; H Hata; Yoshimi Misu
Evidence that endogenous catecholamines are involved in alpha 2-adrenoceptor-mediated modulation of the aortic baroreceptor reflex in the nucleus tractus solitarii of the rat.
Brain research 1990;526(2):313-7.
1990: Yoshimi Misu; Yoshio Goshima; S Nakamura; T Kubo
Nicotine releases stereoselectively and Ca2(+)-dependently endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.
Brain research 1990;520(1-2):334-7.
1990: N Arai; K Misugi; Yoshio Goshima; Yoshimi Misu
Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.
Brain research 1990;515(1-2):57-63.
1990: Yoshimi Misu; M Kuwahara; Yoshio Goshima; T Kubo
Stress-induced increases in adrenaline further activate tonically presynaptic beta-adrenoceptors in renal arteries from prehypertensive rats of spontaneously hypertensive strain.
Archives internationales de pharmacodynamie et de thérapie 1990;305():100-10.
1990: Yoshio Goshima; S Nakamura; Yoshimi Misu
L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
Japanese journal of pharmacology 1990;53(1):47-56.
1990: K Ohno; S Nakamura; Yoshio Goshima; Yoshimi Misu
Carteolol is a useful tool to prove the tonically functioning nature of presynaptic beta-adrenoceptors on peripheral noradrenergic neurons but not on central catecholaminergic neurons.
Japanese journal of pharmacology 1990;52(4):643-6.
1990: T Kubo; Minoru Kihara; Yoshimi Misu
Electrical stimulation-evoked release of endogenous aspartate from rat medulla oblongata slices. Effects of inhibitors of aspartate aminotransferase and GABA transaminase.
Naunyn-Schmiedeberg's archives of pharmacology 1990;341(3):221-4.
1990: Yoshio Goshima; S Nakamura; Yoshimi Misu
L-dopa methyl ester antagonizes competitively L-dopa-induced facilitation of noradrenaline release from rat hypothalamic slices.
Japanese journal of pharmacology 1990;52(1):174-7.
1990: T Kubo; Minoru Kihara; Yoshimi Misu
Genetically altered brain amino acid metabolism in spontaneously hypertensive rats: a study by using young spontaneously hypertensive rats and renal hypertensive rats.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(7):1191-201.
1990: T Kubo; Minoru Kihara; Yoshimi Misu
Hypotension decreases GABA levels in brainstem regions of the rat.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(3):317-24.
1989: M Kuwahara; T Kubo; Yoshimi Misu
Isoproterenol-induced facilitation of norepinephrine release does not primarily involve a local angiotensin II mechanism in guinea pig pulmonary arteries.
Japanese journal of pharmacology 1989;51(2):302-5.
1989: Yoshimi Misu; M Kuwahara; H Amano; T Kubo
Evidence for tonic activation of prejunctional beta-adrenoceptors in guinea-pig pulmonary arteries by adrenaline derived from the adrenal medulla.
British journal of pharmacology 1989;98(1):45-50.
1989: Minoru Kihara; H Amano; Yoshimi Misu; T Kubo
Release of [3H]- and endogenous GABA from slices of the rat medulla oblongata: modification by 3-mercaptopropionic acid, nipecotic acid and diaminobutyric acid.
Archives internationales de pharmacodynamie et de thérapie 1989;298():50-60.
1989: T Kubo; H Amano; K Kurahashi; Yoshimi Misu
Nicotine-induced regional changes in brain noradrenaline and dopamine turnover in rats.
Journal of pharmacobio-dynamics 1989;12(2):107-12.
1989: H Amano; Yoshio Goshima; N Akema; H Ueda; T Kubo; Yoshimi Misu
Effects of acute nicotine on catecholamine turnover in various rat brain regions.
Journal of pharmacobio-dynamics 1989;12(1):18-23.
1989: Minoru Kihara; Yoshimi Misu; T Kubo
Release by electrical stimulation of endogenous glutamate, gamma-aminobutyric acid, and other amino acids from slices of the rat medulla oblongata.
Journal of neurochemistry 1989;52(1):261-7.
1989: T Kubo; Minoru Kihara; Yoshimi Misu
Altered amino acid levels in brainstem regions of spontaneously hypertensive rats.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11(2):233-41.
1988: Yoshimi Misu; M Kuwahara; H Amano; T Kubo
Adrenaline as an endogenous agonist for presynaptic beta-adrenoceptors and their relevance to the development of hypertension in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S572-4.
1988: G Yasuda; Yoshimi Misu
Effects of prostaglandins E1, E2, F2 alpha and I2 on adrenergic transmission in guinea pig pulmonary arteries.
Japanese journal of pharmacology 1988;48(1):153-6.
1988: Yoshio Goshima; T Kubo; Yoshimi Misu
Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.
Journal of neurochemistry 1988;50(6):1725-30.
1988: T Kubo; H Amano; Yoshimi Misu
Regional changes in brain noradrenergic activity elicited by a decrease in blood pressure.
Journal of pharmacobio-dynamics 1988;11(3):198-201.
1988: Minoru Kihara; Yoshimi Misu; T Kubo
GABA transaminase inhibitors enhance the release of endogenous GABA but decrease the release of beta-alanine evoked by electrical stimulation of slices of the rat medulla oblongata.
Life sciences 1988;42(19):1817-24.
1988: T Kubo; H Hata; Yoshimi Misu
Involvement of spinal alpha adrenoceptors in mediation of the hypotensive action of guanabenz in rats.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(1):122-4.
1987: Minoru Kihara; T Kubo; Yoshimi Misu
Potassium induced release of endogenous glutamate, gamma-aminobutyric acid (GABA) and glycine from the caudal dorsomedial medulla of the rat.
Journal of pharmacobio-dynamics 1987;10(12):727-9.
1987: Gen Yasuda; Hiroshi Shionoiri; T Kubo; Yoshimi Misu
Presynaptic angiotensin II receptors and captopril-induced adrenergic transmission failure probably not via converting enzyme inhibition in guinea-pig pulmonary arteries.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(2):S39-45.